Evidence map›Paper›PMID 35837868›Full record

Trial reportMedical physics2022

Prediction of potential severe coronavirus disease 2019 patients based on CT radiomics: A retrospective study.

Feng Xiao, Rongqing Sun, Wenbo Sun, Dan Xu, Lan Lan, Huan Li, Huan Liu, Haibo Xu

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Medical physics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Feng XiaoDepartment of Radiology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Rongqing SunDepartment of Radiology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Wenbo SunDepartment of Radiology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Dan XuDepartment of Radiology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Lan LanDepartment of Radiology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Huan LiDepartment of Radiology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Huan LiuGE Healthcare, Shanghai, China.
Haibo XuDepartment of Radiology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Zhongnan Hospital of Wuhan University · CNWuhan University · CNUnited Imaging Healthcare (China) · CN

Funding

Applied Basic Frontier Research Foundation of Wuhan Science and Technology Bureau 2020020601012238Fundamental Research Funds for the Central Universities 2042020kfxg11National Key Research and Development Plan of China 2017YFC0108803New Type Pneumonia Emergency Science and Technology Project of Hubei Province 2020FCA016
6 · The paper itself

Abstract

purposeCoronavirus disease 2019 (COVID-19) is a recently declared worldwide pandemic. Triaging of patients into severe and non-severe could further help in targeted management. "Potential severe patients" is a category of patients who did not have severe symptoms at their initial diagnosis, but eventually progressed to be severe patients and are easily overlooked in the early stage. This work aimed to develop and evaluate a CT-based radiomics signature for the prediction of these potential severe COVID-19 patients.

methodsOne hundred fifty COVID-19 patients were enrolled and randomly divided into cross-validation and independent test sets. First, their clinical characteristics were screened using the univariate and multivariate logistic regression step by step. Then, radiomics features were extracted from the lesions on their chest CT images. Subsequently, the inter- and intra-class correlation coefficients (ICC) analysis, minimum-redundancy maximum-relevance (mRMR) selection, and the least absolute shrinkage and selection operator (LASSO) algorithm were used step by step for feature selection and construction of a radiomics signature. Finally, the screened clinical risk factors and constructed radiomics signature were combined for the combined model and Radiomics+Clinics nomogram construction. The predictive performance of the Radiomics and Combined models were evaluated and compared using receiver operating characteristic curve (ROC) analysis, Hosmer-Lemeshow test and Delong test.

resultsClinical characteristics analysis resulted in the screening of five clinical risk factors. The combination of ICC, mRMR, and LASSO methods resulted in the selection of ten radiomics features, which made up of the radiomics signature. The differences in the radiomics signature between the potential severe and non-severe groups in cross-validation set and test sets were both p < 0.001. All Radiomics and Combined models showed a very good predictive performance with the accuracy and AUC of nearly or above 0.9. Additionally, we found no significant difference in the predictive performance between these two models.

conclusionsA CT-based radiomics signature for the prediction of potential severe COVID-19 patients was constructed and evaluated. Constructed Radiomics and Combined model showed good feasibility and accuracy. The Radiomics+Clinical nomogram, acted as a useful tool, may assist clinicians to better identify potential severe cases to target their management in the COVID-19 pandemic prevention and control.

Indexed as

COVID-19HumansNomogramsPandemicsRetrospective StudiesTomography, X-Ray ComputedCOVID-19CT radiomicspotential severe patientprediction

Identifiers

PMID35837868
PMCPMC9349830
OpenAlexW4285589842

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.